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Loss of Usp9x disrupts cell 
adhesion, and components of the 
Wnt and Notch signaling pathways 
in neural progenitors
Susitha Premarathne1, Mariyam Murtaza1, Nicholas Matigian1,3, Lachlan A. Jolly2 & Stephen 
A. Wood  1
Development of neural progenitors depends upon the coordination of appropriate intrinsic responses 
to extrinsic signalling pathways. Here we show the deubiquitylating enzyme, Usp9x regulates 
components of both intrinsic and extrinsic fate determinants. Nestin-cre mediated ablation of Usp9x 
from embryonic neural progenitors in vivo resulted in a transient disruption of cell adhesion and apical-
basal polarity and, an increased number and ectopic localisation of intermediate neural progenitors. 
In contrast to other adhesion and polarity proteins, levels of β-catenin protein, especially S33/S37/T41 
phospho-β-catenin, were markedly increased in Usp9x−/Y embryonic cortices. Loss of Usp9x altered 
composition of the β-catenin destruction complex possibly impeding degradation of S33/S37/T41 
phospho-β-catenin. Pathway analysis of transcriptomic data identified Wnt signalling as significantly 
affected in Usp9x−/Y embryonic brains. Depletion of Usp9x in cultured human neural progenitors 
resulted in Wnt-reporter activation. Usp9x also regulated components of the Notch signalling pathway. 
Usp9x co-localized and associated with both Itch and Numb in embryonic neocortices. Loss of Usp9x 
led to decreased Itch and Numb levels, and a concomitant increase in levels of the Notch intracellular 
domain as well as, increased expression of the Notch target gene Hes5. Therefore Usp9x modulates and 
potentially coordinates multiple fate determinants in neural progenitors.
Neural progenitors (NPs) are the founding cell population driving brain development. Therefore, cell fate deci-
sions taken by NPs must balance their differentiation into neuronal and glial lineages, with self-renewal thereby 
facilitating ongoing growth. The fate of a NP is temporally and spatially controlled by the simultaneous expo-
sure to multiple extrinsic signalling pathways to which NPs need to coordinate appropriate intrinsic responses1. 
Post-translational protein modifications play critical roles in mediating and dynamically integrating signalling 
pathways. Although the role of phosphorylation in signal transduction is well established it is clear that ubiqui-
tylation/deubiquitylation also play critical roles in both NP fate and signal pathway regulation2. In the current 
study we focused on the role of deubiquitylating enzyme (DUB), ubiquitin specific peptidase 9 located in the 
X-chromosome (Usp9x) in the regulation of NP function in the mouse neocortex.
Usp9x is ideally situated to integrate extrinsic signals with intrinsic responses in NPs. Usp9x is highly expressed 
in both embryonic and adult NPs3–5. Conditional deletion of Usp9x from mouse NPs results in perinatal lethality 
and disrupts the cytoarchitecture of the ventricular and sub ventricular zones in late stage embryos6. Conversely 
overexpression of Usp9x in mouse embryonic stem cell-derived NPs significantly increased their polarity and 
self-renewal without affecting their differentiation capacity3. Although these studies demonstrate the importance 
of Usp9x in NP fate specification, the underlying molecular mechanism(s) remains to be elucidated. To date more 
than 35 proteins have been reported as Usp9x substrates, many of which are components of intrinsic and extrin-
sic signalling pathways known to regulate NP function5. However, as these Usp9x-substrate interactions were 
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elucidated in diverse biological systems, and are often cell context specific, further characterisation of Usp9x’s 
role in NPs is required.
Cell adhesion and apical-basal polarity are key intrinsic regulators of NP fate1 and Usp9x regulates both in a 
number of polarised cells. Adherens junctions (AJ) are the predominant cell-cell adhesive structures in NPs and, 
Usp9x substrates AF-67 and EFA68 are key functional adhesion components. In addition Usp9x has been pro-
posed to promote the trafficking of cadherin-catenin heterodimers during de novo AJ formation of T84 epithelial 
cells9. Deubiquitylation by Usp9x also activates the polarity regulatory proteins AMP-activated protein kinase 
related kinesin proteins NUAK1 and MARK4 in polarised epithelia10, 11. Functionally, cellular polarity was up 
regulated with modest overexpression of Usp9x in embryonic stem cell-derived NPs3.
Usp9x also regulates components of the Notch and Wnt signalling pathways, which are prominent extrinsic 
signalling pathways specifying NP fate12. The best-characterised role of Notch signalling in neural development 
is the maintenance of NP self-renewal. Usp9x is capable of regulating the Notch pathway at multiple levels. Usp9x 
promotes Notch signalling by antagonising the degradation of Mind bomb1, as well as activating Epsin in the 
signal sending cell13, 14. Conversely, Usp9x potentially opposes Notch signalling by stabilising the Itch E3 ligase15, 
which targets the Notch intracellular domain (NICD) for proteasomal degradation in the signal receiving cell. 
Although no direct evidence has been reported on Usp9x regulation of Wnt signalling, the catalytic domain of 
Usp9x binds β-catenin and increases the half-life of the cytosolic pool16. Recently, two studies also identified 
Usp9x associated with the β-catenin destruction complex in HEK293 cells17, 18 suggesting another intersection 
between Usp9x and Wnt signalling. Therefore Usp9x interacts with both intrinsic and extrinsic mechanisms reg-
ulating NP fate specification. In the current study we sought to directly determine if Usp9x regulates NP function 
in vivo and if so, determine the molecular mechanism(s) involved.
Results
Usp9x regulates adherens junctions and polarity in early neural progenitors. Nestin-cre medi-
ated deletion of Usp9x from mouse NPs results in their disorganisation, and that of their derivatives, within the 
neocortex of late stage embryos (Stegeman et al.6). However, earlier time points have not been investigated. In this 
study we directly examined the role of Usp9x in NPs using Usp9x conditionally deleted mice (Usp9x−/Y) following 
mating of Usp9xflox/flox females with Nestin-Cre males6.
Usp9x protein is robustly expressed throughout the neocortex during the neurogenic period (Fig. 1A,B,E). 
Immunohistochemical (IHC) and immunoblot (IB) analyses of Usp9x−/Y animals compared to litter mate con-
trols (Usp9x+/Y) (n = 7) identified E12.5 as the earliest stage at which Usp9x protein was depleted from Usp9x−/Y 
neocortices (Fig. 1A,B). Given the disorganisation of cells in the late embryonic neocortex6 and established role of 
Usp9x in cell adhesion and polarity3, 8, 9, 19 we assessed the status of AJ and polarity proteins in NPs.
At E12.5, loss of Usp9x coincided with decreased levels of several AJ and polarity proteins. Immunoreactivity 
of N-cadherin was markedly reduced in Usp9x−/Y ventricular zones (VZs) (n = 3) (Fig. 1A, Supp. Fig. S1A). 
Similarly, immunoreactivity of Usp9x substrate and AJ structural protein AF-6 was also reduced (n = 3) (Fig. 1A, 
Supp. Fig. S1B). Significantly reduced N-cadherin and AF-6 total protein levels in Usp9x−/Y neocortices were con-
firmed by IB analyses (n = 3) (Fig. 1B,C). Immunoreactivity of apical polarity proteins aPKCλ, Par3, Prominin1 
and the basal polarity protein Scribble was also markedly reduced in Usp9x−/Y VZs (n = 3) (Fig. 1A). Significantly 
reduced aPKCλ expression was confirmed by IB (n = 3) (Fig. 1B,C). Together these data suggest AJs and polar-
ity were perturbed in E12.5 Usp9x−/Y NPs. Interestingly however, both IHC and IB analyses of the same AJ and 
polarity markers 48 hours later, at E14.5, failed to detect any difference between Usp9x−/Y and Usp9x+/Y NPs 
(Fig. 1D–F) suggesting AJs and apical-basal polarity, at least at this level of analysis, had been restored.
To further analyse the effect of Usp9x loss on adhesion and polarity, as indicated by the IHC and IB results, 
we conducted a microarray analysis on Usp9x−/Y E12.5 and E14.5 mouse neocortical tissues. At E12.5 over 1000 
genes were differentially expressed between the Usp9x+/Y and Usp9x−/Y samples, at a significance level of p < 0.05 
(n = 4 for each genotype) (Supp. Fig. S2). In concordance with perturbed polarity, the functional annotation of 
the differentially expressed genes at E12.5 identified cytoskeleton organisation and cell to cell signalling interac-
tions as the most significantly affected in addition to nervous system development and function (Supp. Table S1). 
Despite the apparent restoration of normal NP adhesion and polarity at E14.5 (Fig. 1) nearly 1400 genes (Supp. 
Fig. S3) were significantly (p < 0.05) differentially expressed (n = 4) (Supp. Table S2). The affected functions 
included tissue morphology and, cell growth and proliferation. However, only 147 genes were common to both 
E14.5 and E12.5 (Supp. Table S3). Therefore, loss of Usp9x affects the expression of a large number of genes and a 
range of NP functions, and these differ at E12.5 and E14.5. Additionally, despite the apparent restoration of adhe-
sion and polarity at E14.5, multiple gene networks remained perturbed in the absence of Usp9x.
Deletion of USP9X affects the fate of apical neural progenitors. The adhesion and polarity of apical 
NPs in the neocortex creates a niche maintaining NP fate. Once NPs lose apical cell-cell adhesion, migration out-
ward from the VZ occurs and their fate is restricted to either basally located intermediate progenitors or termi-
nally differentiated neurons or glia20, 21. Therefore an examination of the consequences of the transient disruption 
of cell adhesion and polarity on the fate of Usp9x−/Y NPs was conducted.
The proliferative state of Usp9x−/Y NPs was assessed by measuring the number of NPs undergoing mitosis as 
marked by antibodies against phospho-histone3 (PH3). Although no difference was observed in the number of 
PH3-positive (PH3+) mitotic cells at the ventricular surface between Usp9x+/Y and Usp9x−/Y neocortices at either 
E12.5 or E14.5, a 6-fold increase in abventricular PH3+ nuclei was detected at E12.5 (Usp9x+/Y = 0.0209 ± 0.0138 
PH3 + cells/μm; Usp9x−/Y = 0.1326 ± 0.1546; p < 0.01, n = 4) (Fig. 2A,B), and a 2-fold increase was evident at 
E14.5 (Usp9x+/Y = 0.1046 ± 0.040; Usp9x−/Y 0.1989 ± 0.038; p < 0.01, n = 4) (Fig. 2A,C) in Usp9x−/Y neocorti-
ces. To identify the nature of the abventricularly proliferating cells, sections were double-stained with the apical 
NP marker Pax6 and intermediate progenitor marker, Tbr2. The majority of PH3+ abventricular cells were also 
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Figure 1. Usp9x regulates polarity and adherens junction proteins in neural progenitors. (A) Coronal sections of 
E12.5 Usp9x+/Y and Usp9x−/Y neocortices stained for Usp9x, cell adhesion and polarity markers. Usp9x protein is 
expressed throughout the E12.5 Usp9x+/Y ventricular zone (VZ) (a) and depleted following Nestin-cre mediated 
deletion (b) (each image represents n = 3 Usp9x+/Y and Usp9x−/Y embryos). Immunoreactivity of the adherens 
junction-associated proteins N-cadherin (c,d) and AF-6 (e,f) as well as apical polarity markers aPKCλ (g,h), 
Par3 (i,j), Scribble (k,l) and Prominin1 (m,n) was reduced in Usp9x−/Y NPs compared to Usp9x+/Y NPs (n = 3). 
(B) Immunoblot analyses of total Usp9x, N-cadherin, AF-6 and aPKCλ protein levels in E12.5 Usp9x+/Y and 
Usp9x−/Y neocortices from n = 3 embryos each. (C) Quantification of protein levels in (B) relative to β-tubulin. 
(D) Coronal sections of E14.5 Usp9x+/Y and Usp9x−/Y neocortices stained with adhesion and polarity markers 
(n = 3). No difference was observed between Usp9x+/Y and Usp9x−/Y neocortices for the immunostaining pattern 
or intensity of N-cadherin (o,p), AF-6 (q,r), aPKCλ (s,t), Par3 (u,v) or Scribble (w,x). (E) Immunoblot analyses 
of neocortical lysates confirming depletion of Usp9x and restored N-cadherin, AF-6 and aPKCλ protein levels 
in E14.5 Usp9x−/Y brains. (F) Quantification of protein levels in (E) relative to β-tubulin. Scale bars = 80 μm. LV- 
lateral ventricle, VZ- ventricular zone. All data are shown as the means ± SEM. *p < 0.05.
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Figure 2. Loss of Usp9x leads to the premature appearance and ectopic location of intermediate progenitors but 
does not alter neurogenesis in the neocortex. (A) Phosphohistone3 (PH3) labels mitotic cells at the ventricular 
surface in E12.5 and E14.5 Usp9x+/Y neocortices (a,c), but mitotic cells were also detected in abventricular 
locations in Usp9x−/Y neocortices (b,d). Tbr2+ intermediate progenitors in Usp9x+/Y neocortex located 
exclusively in the subventricular zone and few labelled with PH3 (e). In Usp9x−/Y neocortex Tbr2+ cells in both 
ventricular and subventricular zones are frequently labelled with PH3 (f) (representative of n = 4 embryos 
for each). Number of abventricularly proliferating PH3+ cells was significantly increased in both E12.5 (B) 
and E14.5 (C) Usp9x−/Y neocortices. (D) Increased Tbr2+ intermediate progenitor cell number in Usp9x−/Y 
neocortices. Number of Tbr2+ intermediate progenitor per unit area was significantly increased in E12.5 
Usp9x−/Y neocortices (E), but not in E14.5 Usp9x−/Y brains (F). Number of EdU+/Tbr2+ double-labelled cells 
was increased in E12.5 Usp9x−/Y neocortices (G), but not E14.5 Usp9x−/Y neocortices (H). (I) Loss of Usp9x does 
not alter overall proportions of neural progenitors or neuroblast. Coronal sections of E12.5 and E14.5 Usp9x+/Y 
and Usp9x−/Y neocortices stained with the neural progenitor marker Sox2 (a–d) and neuroblast marker DCX 
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positive for Tbr2 in the Usp9x−/Y brains (n = 3) (Fig. 2A). An increased density of Tbr2+ cells within the neocor-
tex in Usp9x−/Y brains at E12.5 (Usp9x+/Y = 0.33 ± 0.02 Tbr2+ cells/μm2; Usp9x−/Y = 0.41 ± 0.004 Tbr2+ cells/μm2; 
p < 0.05, n = 3) but not E14.5 (Usp9x+/Y = 0.16 ± 0.001 Tbr2+ cells/μm2; Usp9x−/Y 0.16 ± 0.003 Tbr2+ cells/μm2; 
p = 0.52, n = 3) (Fig. 2D–F) was also observed. In the Usp9x−/Y neocortex Tbr2+ cells were not restricted to the 
sub ventricular zone with many located in the ventricular zone, some of which were also PH3 positive (Fig. 2A), 
consistent with a premature differentiation of apical progenitors as occurs following the loss of other cell adhesion 
and polarity proteins22, 23. To investigate, Tbr2 immunostaining was conducted on brain sections following an in 
vivo 3 hour EdU pulse. In agreement with the previous results, the number of EdU+/Tbr2+ cells were significantly 
increased in E12.5 Usp9x−/Y brains (Usp9x+/Y = 35.00 ± 4.58; Usp9x−/Y = 62.25 ± 6.62; p < 0.05, n = 3) but not at 
E14.5 (Usp9x+/Y = 49.63 ± 1.37; Usp9x−/Y = 52.75 ± 0.25; p = 0.15, n = 3) (Fig. 2D,G,H). At E12.5, some EdU+/
Tbr2+ cells were also located in the VZ but only in Usp9x−/Y samples (Fig. 2D).
Next the effect, if any, of increased intermediate progenitor numbers on subsequent cortical development was 
assessed. No difference was observed in the number of Sox2+ NPs in either E12.5 or E14.5 Usp9x−/Y brains (n = 3) 
(Fig. 2I,J). Similarly, no difference was observed for the number of Tbr1+ mature neurons (Supp. Fig. S4A) or 
Doublecortin positive (Dcx+) neuroblast between Usp9x+/Y and Usp9x−/Y brains in any embryonic stage (E12.5, 
E14.5, E16.5, E18.5) (n = 3) (Fig. 2I–K, Supp. Fig. S4B) suggesting overall neurogenesis was not overtly affected. 
Nevertheless, cortical lamination patterns were also assessed. Late embryonic (E18.5) brains were stained with 
Ctip2 and Satb2 antibodies to label deep-layered and superficial-layered neurons, respectively. No difference was 
observed in the number of Satb2+ (Fig. 2L,M) or Ctip2+ (Fig. 2L,N) neurons between Usp9x+/Y and Usp9x−/Y 
neocortices (n = 3). To ensure this was not due to the loss of early born deep-layered neurons in Usp9x−/Y brains, 
apoptosis was examined using cleaved Caspase3 (Cas3) antibodies and TUNEL assay at E12.5, E14.5, E16.5 and 
E18.5. No difference was observed in Usp9x−/Y brains with either Cas3 (Supp. Fig. S5A) or TUNEL assays (Supp. 
Fig. S5B) (n = 3) confirming that deep and superficial neuronal generation and/or radial migration was unaf-
fected in Usp9x−/Y brains.
Deletion of Usp9x increases the levels of β-catenin protein in Neural Progenitors. Surprisingly, 
and in contrast to other adhesion proteins, β-catenin protein levels were significantly increased in Usp9x−/Y brains 
in both IHC and IB analyses, across all embryonic stages examined (n = 3) (Fig. 3A–C). Even at E12.5, when other 
AJ and polarity proteins were downregulated, β-catenin protein was significantly increased. To determine the 
source of the increased β-catenin proteins, its transcriptional level was assessed by qRT-PCR analysis using RNA 
extracted from the neocortex at E12.5 and E14.5. No differences in β-catenin RNA levels were observed between 
Usp9x−/Y and Usp9x+/Y samples at either stage (n = 3) (Fig. 3D). Therefore, the increased β-catenin protein levels 
in Usp9x−/Y brains were due to translational or post-translational mechanisms.
β-catenin acts as both an essential linker protein in cadherin-based cell adhesion as well as a co-activator of 
canonical Wnt signalling24, 25. Under normal physiological conditions there are three cellular pools of β-catenin 
in NPs; (i) membrane associated β-catenin at AJs, (ii) soluble cytoplasmic β-catenin and, (iii) transcriptionally 
activated β-catenin in the nucleus24. Therefore β-catenin levels in each cellular pool were measured to identify 
which β-catenin species was upregulated in Usp9x−/Y NPs.
First, the cadherin associated β-catenin pool was examined by co-immunoprecipitation. The normal stoi-
chiometry between β-catenin and N-cadherin and α-catenin was evident in E14.5 (Fig. 3E) and E12.5 (Supp. 
Fig. S6A) Usp9x−/Y brains suggesting the increased β-catenin protein levels were not attributable to its accu-
mulation at AJs. The cytoplasmic and nuclear pools of β-catenin were also assessed. Under physiological con-
ditions the majority of cytoplasmic β-catenin is efficiently bound, phosphorylated and ubiquitylated by the 
β-catenin destruction complex17. This sub-population of β-catenin can be identified by the phosphorylation of 
the amino acid residues Serine 33/37 and Threonine 41 (pβ-catenin33/37/41). Strikingly, a 6-fold increase in 
pβ-catenin33/37/41 was detected in Usp9x−/Y brains at E14.5 (n = 3) (Fig. 3F,G). In addition a slight, but signif-
icant, increase in the transcriptionally activated form of β-catenin (Tyr654 pβ-catenin)26 was also detected in 
Usp9x−/Y lysates at E14.5 (n = 3) (Fig. 3F,H).
Absence of Usp9x alters relative ratios of proteins in the β-catenin destruction complex. A 
direct physical interaction between Usp9x and β-catenin has been observed in several in-vitro systems9, 16, 27. In 
line with these studies, Usp9x was co-immunopercipitated with β-catenin from E14.5 Usp9x+/Y neocortical lysates 
extending this interaction in-vivo (Fig. 3E). However, in contrast to previous studies, which indicated Usp9x pos-
itively regulates β-catenin protein levels, significantly increased pβ-catenin33/37/41 and Tyr654 pβ-catenin levels 
observed in Usp9x−/Y neocortices implied a novel regulatory mechanism in NPs.
Interestingly, two studies using mass spectrometry analysis identified Usp9x as a component of the β-catenin 
destruction complex in HEK293 cells17, 18. First, we confirmed these results by co-immunoprecipitating Usp9x 
with Axin and APC from HEK293 cell lysates, using only endogenous proteins in each case (Fig. 4A,B). Using 
(e–h) (n = 3). Dotted lines demark the borders between the ventricular zone (VZ) and cortical plate (CP). (J,K) 
Comparison of relative thickness of average Sox2 and DCX staining in E12.5 and E14.5 neocortices revealed 
no differences between the Usp9x+/Y and Usp9x−/Y samples. (L) Coronal sections of E18.5 Usp9x+/Y (a–c) and 
Usp9x−/Y (d–f) cortices stained with deep layer neuronal marker Ctip2 (layer V) and superficial neuronal 
marker Satb2 (n = 3). Number of Ctip2+ and Satb2+ cells were normalised to total number of cells present as 
marked by DAPI staining. (M,N) No difference was observed for Ctip2+ and Satb2+ cell percentage between 
E18.5 Usp9x+/Y and Usp9x−/Y brains. Scale bars = 80 μm. LV- lateral ventricle, VZ- ventricular zone, CP- cortical 
plate. **p < 0.01; *p < 0.05.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 8109  | DOI:10.1038/s41598-017-05451-5
Figure 3. Usp9x regulates β-catenin protein levels in neural progenitors. (A) Coronal sections of Usp9x+/Y 
and Usp9x−/Y neocortices. In the Usp9x+/Y neocortex (a,c,e,g) β-catenin is predominantly localised to the 
apical region of the ventricular zone (VZ) (white arrows). Overall β-catenin staining was increased in Usp9x−/Y 
neocortices (b,d,f,h) spreading throughout the cytoplasm (yellow arrows) at all embryonic stages from E12.5 
to E18.5 (n = 3 for each stage). (B) Immunoblot analysis confirmed increased total β-catenin levels in Usp9x−/Y 
cortex at each embryonic stage (n = 3). (C) Quantification of protein levels in (B) relative to β-tubulin. (D) 
Quantitative RT-PCR revealed no difference in Ctnnb1 gene expression between Usp9x+/Y and Usp9x−/Y 
neocortices at E12.5 or E14.5 (n = 3). (E) β-catenin co-immunoprecipitated similar levels of N-cadherin and 
α-catenin from Usp9x+/Y and Usp9x−/Y brains. An interaction with Usp9x protein was also identified in Usp9x+/Y 
cortical lysate. (F) Immunoblot showing increased S33/37/T41 pβ-catenin and Tyr654 pβ-catenin levels in 
E14.5 Usp9x−/Y neorcortices (n = 3). (G,H) Quantification of protein levels in (F) relative to β-tubulin. Scale 
bars = 80 μm. LV- lateral ventricle, VZ- ventricular zone. **p < 0.01; *p < 0.05.
www.nature.com/scientificreports/
7Scientific RepoRts | 7: 8109  | DOI:10.1038/s41598-017-05451-5
Figure 4. Relative ratios of β-catenin destruction complex components are altered in Usp9x−/Y neocortices. 
(A–C) Usp9x is part of the β-catenin destruction complex. Endogenous USP9X co-immunoprecipitated from 
HEK293 lysate along with components of the β-catenin destruction complex using Axin antibody (A) and 
APC antibody (B). (C) Usp9x immunoprecipitated by Axin antibody from E14.5 Usp9x+/Y cortical lysate along 
with other components of the destruction complex. (D) Immunoblot analysis of β-TrCP protein levels in 
Usp9x+/Y and Usp9x−/Y neocortices at E12.5 and E14.5 (n = 3). (E) Quantitation of (D) revealed no difference 
in total β-TrCP protein levels between Usp9x+/Y and Usp9x−/Y neocortices at E12.5 or E14.5. (F) Components 
of destruction complex were co-immunoprecipitated by anti-APC antibody from E14.5 Usp9x+/Y and Usp9x−/Y 
cortical lysate. Relatively more β-TrCP and GSK-3β were immunoprecipitated from Usp9x−/Y compared to 
Usp9x+/Y. (G) Co-immunoprecipitation of destruction complex components using anti-β-TrCP antibody. 
Increased GSK-3β protein level co-immunoprecipitated from Usp9x−/Y cortical lysate confirming increased 
interaction with β-TrCP.
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the same conditions endogenous Axin co-immunoprecipitated with Usp9x, other components of the destruction 
complex, APC and GSK3β, as well as the substrate β-catenin, from E14.5 neocortical lysates, which contain a high 
percentage of NPs (Fig. 4C). These data confirm that a subset of Usp9x associates with the β-catenin destruction 
complex in HEK293 cells and NPs in-vivo.
The increased levels of pβ-catenin33/37/41 in the Usp9x−/Y neocortex suggested decreased proteasomal deg-
radation of β-catenin, which is targeted for ubiquitylation by the E3 ligase β-TrCP. However, no difference in 
total β-TrCP protein level was observed by WB at either E12.5 or E14.5 (n = 3) (Fig. 4D,E). Ubiquitylation of 
pβ-catenin33/37/41 occurs within the destruction complex17. These results raised the prospect that loss of Usp9x 
perturbed the assembly, composition and/or activity of the destruction complex. No difference was observed 
in total APC or GKS-3β protein levels in Usp9x−/Y brains at E12.5 or E14.5 (n = 3) (Supp. Fig. S6B–I). Next 
the assembly of the destruction complex in Usp9x−/Y brains was assessed at E14.5, the earliest time point with 
increased cytoplasmic β-catenin but normal levels of other adhesion and polarity proteins. The destruction com-
plex is a static multiprotein complex therefore its protein composition remains constant and so immunoprecipita-
tion of endogenous proteins should reveal structural differences between Usp9x−/Y and Usp9x+/Y samples17, 28. All 
destruction complex components analysed co-immunoprecipitated from Usp9x−/Y brains (Fig. 4F, representative 
of two biological replicates), suggesting the absence of Usp9x did not prevent its assembly. Indeed, unexpectedly 
higher levels of Gsk-3β and β-TrCP co-immunoprecipitated from Usp9x−/Y cortical lysates (Fig. 4F) implying 
their increased interaction/presence within the complex. Co-immunoprecipitation using β-TrCP antibody cor-
roborated the APC result revealing increased levels of GKS-3β protein from Usp9x−/Y lysates (Fig. 4G).
Usp9x antagonises Wnt signalling in neural progenitors. Next we examined whether the increased 
β-catenin protein levels, especially Tyr654 pβ-catenin, in the Usp9x−/Y brains activated the Wnt signalling path-
way by assaying target gene levels using qRT-PCR. Consistent with the preceding results significantly increased 
Ccnd1 and Axin2 gene expression levels were observed in the Usp9x−/Y brains at E12.5, E14.5 and E16.5 (n = 3) 
(Fig. 5A,B). However, the levels of target gene induction varied widely (50% to 80% for Ccnd1; 5% for Axin2). 
Ingenuity pathway analysis conducted on the microarray data independently identified Wnt signalling as one the 
most significantly affected pathways in Usp9x−/Y brains (Table S3). Further, qRT-PCR analysis confirmed changes 
in the expression level of the Wnt pathway genes identified by Ingenuity, in E12.5 Usp9x−/Y brains (Supp. Fig. S7) 
but only Sox4 and Sox1 were significantly affected at E14.5. Although these genes impact upon Wnt signalling 
they are not direct Wnt targets.
Therefore, to test if loss of Usp9x can directly activate Wnt signalling, TCF-TOPflash reporter assays were 
performed on HEK293 cells from which USP9X was depleted with siRNA. USP9X protein level was depleted 
72 hours after siRNA transfection and a clear increase in pβ-catenin33/37/41 protein level was observed (Supp. 
Fig. S6J). Increased luciferase activity was also observed in USP9X-depleted HEK293 cells (n = 3) (Fig. 5C). The 
addition of optimised concentrations of exogenous Wnt3a increased luciferase activity in HEK293 cells treated 
with control shRNA. However, exogenous Wnt3a did not induce higher levels of luciferase activity than depletion 
of USP9X alone (Fig. 5C). In contrast, addition of the extracellular Wnt inhibitor DKK1, did not alter luciferase 
activity in USP9X-depleted cells but significantly reduced it in control shRNA treated cells (n = 3) (Fig. 5C). 
Therefore depletion of USP9X is capable of directly activating Wnt target gene expression.
The embryonic neocortex is composed of multiple types of NPs and fate restricted neural cells. Therefore, 
to test the effect of Usp9x loss on Wnt target gene expression in a homogeneous NP population, USP9X was 
depleted in the human NP cell line, ReNcell VM, using doxycycline inducible shRNA against USP9X29. 72 hours 
after shRNA induction, USP9X protein was almost completely depleted in these cells (Fig. 5D). Consistent with 
the in-vivo results, USP9X-depleted ReNcell VM cells showed increased β-catenin protein levels (Fig. 5D), a 
10-fold increase in CCND1 gene expression, and a modest (25%) but significant increase in AXIN2 expression 
(n = 3) (Fig. 5E). To determine whether the USP9X DUB activity is required for β-catenin regulation, ReNcell 
VM cells were treated with the DUB inhibitor WP1130, which inhibits the USP9X DUB activity without affect-
ing its protein levels30–32. Similar to in-vivo and shRNA-induced USP9X depletion, β-catenin protein level was 
markedly increased in WP1130 treated ReNcell VM cells to the same level as proteasome inhibition (epoxomicin 
treatment) (Fig. 5G). A caveat to these results is that WP1130 inhibition is not exclusive to USP9X30. However as 
all other DUBs stabilise β-catenin protein levels33–36 their WP1130 inhibition would result in decreased β-catenin 
levels, the opposite of that observed. Finally, as in HEK293 cells, depletion of USP9X increased CCND1 gene 
expression to levels approaching that of exogenous Wnt3a (Fig. 5H) in ReNcell VM NPs. The depletion of USP9X 
in the presence of Wnt3a did not further increase CCDN1 expression. Therefore USP9X depletion increased 
CCND1 expression in ReNcell VM NPs and TOPFlash induction in HEK293 cells but the effect on CCND1 was 
greater.
Notch signalling is activated in Usp9x−/Y brains. Over-expression of stabilised forms of β-catenin and 
activation of Wnt signalling induce both NP self-renewal and neurogenesis during early and mid-neurogenic 
periods, respectively37–40. However, no overt changes in either neurogenesis or total NP numbers were observed 
in early (Fig. 2) or late (Stegeman et al.6) Usp9x−/Y brains. One possible explanation for this apparent discrepancy 
could reside with Usp9x’s regulation of other signalling pathways including Notch, which opposes Wnt signalling 
in multiple progenitor populations41–43. Usp9x regulates components of the Notch pathway in both signal sending 
and receiving cells44. Therefore, we hypothesised that Notch signalling might also be altered in Usp9x−/Y NPs.
To this end, NICD levels were assessed in Usp9x−/Y brains and a 50% increase was detected at both E12.5 and 
E14.5 (p < 0.05) (Fig. 6A,B) raising the possibility of increased Notch signalling. qRT-PCR analysis of Notch tar-
get genes in E12.5, E14.5 and E16.5 revealed Hes5 expression was increased in Usp9x−/Y cortex (20% at E12.5; 16% 
at E14.5; p < 0.05) (Fig. 6C). Much smaller increases were detected for Hes1 at E12.5 and 14.5 and both Hes5 and 
Hes1 at E16.5 (Fig. 6C,D). However, Hes5 more accurately reflects Notch activity than Hes1 in NPs45, 46 suggesting 
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Figure 5. Depletion of Usp9x increases Wnt target gene expression. (A,B) qRT-PCR analysis of RNA isolated 
from E12.5, E14.5 and E16.5 neocortices of Usp9x+/Y and Usp9x−/Y (n = 3). Canonical Wnt signalling target 
genes Ccnd1 (A) and Axin2 (B) were up regulated in the Usp9x−/Y neocortices compared to Usp9x+/Y in all tested 
embryonic stages. (C) TCF-TOPFlash reporter activity was significantly increased in USP9X siRNA transfected 
HEK293 compared to scrambled nonsense siRNA transfected cells. Addition of Wnt3a increased TOPFlash 
reporter activity in scrambled siRNA cells to a level similar to Usp9x siRNA treated cells (n = 3). Addition of the 
Wnt antagonist DKK1, significantly reduced TOPFlash reporter activity only in the Scramble siRNA HEK293 
cells (n = 3). (D) Increased total β-catenin protein levels in USP9X-depleted ReNcell VM. (E,F) Expression of 
canonical Wnt signaling target genes, CCND1 and AXIN2 was significantly increased in USP9X-depleted ReNcell 
VM cells. (G) Inhibition of USP9X deubiquitylating activity in ReNcell VM cells by WP1130 increased total 
β-catenin levels to a level similar to the proteasome inhibitor epoxomicin. DMSO was used as the vehicle control. 
(H) Quantitative RT-PCR analysis of CCND1 gene expression identified significant increases in USP9X-depleted 
ReNcell VMs compared with those expose to Scrambled shRNA. Treatment with Wnt3a increased CCND1 
expression in untreated (WntWT) as well as scrambled and Usp9x shRNA treated ReNcell VMs. Statistical 
significance was assessed by one-way ANOVA, followed by Tukey’s post-test. ***p < 0.001; **p < 0.01; *p < 0.05.
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Figure 6. Increased levels of Notch signalling pathway components in Usp9x−/Y neocortices. (A) Immunoblot 
analysis showing increased levels of Notch intracellular domain (NICD) in E12.5 and E14.5 Usp9x−/Y 
neocortices (n = 3). (B) Quantification of relative NICD protein levels in (A) after normalisation to β-tubulin. 
(C) qRT-PCR analyses showing slightly increased Hes1 and Hes5 gene expression in E12.5, E14.5 and E16.5 
Usp9x−/Y neocortices (n = 3). (E) Immunoblot analysis showing increased BLBP protein levels in E12.5, 
E14.5 and E16.5 Usp9x−/Y neocortices (n = 3). (F) Quantification of relative BLPB protein levels in (E) after 
normalisation to β-tubulin. (G) Coronal sections of E12.5 Usp9x+/Y and Usp9x−/Y neocortices stained with 
Nestin and BLBP (n = 3). BLBP displayed higher immunoreactivity in Usp9x−/Y neocortices (c,d) No difference 
was observed for Nestin expression (a,b). Scale bars = 80 μm. LV- lateral ventricle, VZ- ventricular zone. 
*p < 0.05.
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Usp9x depletion resulted in Notch activation. To examine whether the increased NICD level induced a physio-
logical response, brain lipid binding protein (BLBP) expression, a NP-specific Notch target47 was examined in the 
Usp9x−/Y NPs. Consistent with preceding results increased BLBP protein expression was observed in E12.5, E14.5 
Figure 7. Numb is a novel binding partner of Usp9x. (A) Immunoblot analysis showing reduced Itch protein 
levels in E12.5 and E14.5 Usp9x−/Y neocortices (n = 4). (B) Quantification of Itch protein levels in (A) after 
normalisation to β-tubulin. (C) Coronal sections of E12.5 and E14.5 Usp9x+/Y and Usp9x−/Y neocortices stained 
with Numb (n = 3), showing reduced immunoreactivity in Usp9x−/Y neocortices. (D) Immunoblot analysis of 
reduced Numb protein levels in E12.5 and E14.5 Usp9x−/Y brains (n = 3). (E) Quantification of relative Numb 
protein levels in (D) after normalisation to β-tubulin. (F) Quantification of Numb mRNA level, relative to 
GAPDH, by qRT-PCR at E12.5 and E14.5. n = 4 for each genotype at each stage. (G) Co-immunoprecipitation 
analysis conducted on E14.5 cortical lysates using Usp9x antibody, immunoprecipitated both Numb and 
Itch proteins. (H) Co-immunoprecipitation conducted on E14.5 cortical lysates using Numb antibodies 
immunoprecipitated Usp9x and Itch proteins confirming these proteins forms a complex. Scale bars = 80 μm. 
LV- lateral ventricle, VZ- ventricular zone. *p < 0.05.
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and E16.5 Usp9x−/Y neocortical tissue (n = 3) (Fig. 6E,F). Increased BLBP expression may also have resulted from 
cortical hypertrophy or premature gliogenesis. However, no difference was observed in Nestin or GFAP expres-
sion in Usp9x−/Y cortices at E12.5 (n = 3) (Fig. 6G) or E18.5 (n = 3) (Supp. Fig. S8A,B), respectively, suggesting 
increased BLBP does not reflect changes in cell populations. Similarly, increased HES5 and HES1 expression were 
observed in the USP9X-depleted ReNcell VM NPs as well (Supp. Fig. S8C,D).
Numb protein expression is regulated by Usp9x. Increased NICD levels in Usp9x−/Y brains could 
result from increased receptor activation and/or impaired NICD degradation. Mind bomb1 is an Usp9x sub-
strate, which promotes Notch signalling by activating ligands13, 48 in turn leading to Notch receptor activation 
and increased NICD levels. However, no differences were observed in Mind bomb1 expression in E12.5 or E14.5 
Usp9x−/Y brains (n = 3) (Supp. Fig. S9). Next, the Usp9x substrate E3 ligase Itch was examined. Itch expression was 
significantly reduced in E12.5 and E14.5 Usp9x−/Y brains (n = 4) (Fig. 7A,B) implying increased NICD expression 
may, at least partially, be due to decreased Itch targeting of NICD for proteasomal degradation. In signal receiving 
cells, Numb initiates the binding of Itch to membrane tethered NICD49 and is a well-established Notch antagonist 
in NPs50. Numb protein expression was also significantly reduced in the Usp9x−/Y neocortex at E12.5 and E14.5 
as determined by both IHC and IB analyses (n = 3) (Fig. 7C–E). Interestingly, qRT-PCR conducted on RNA 
extracted from E12.5 cortices showed increased Numb expression in Usp9x−/Y brains, however no difference was 
observed in E14.5 Usp9x−/Y brains (Fig. 7F). These data indicate that the reduced Numb protein expression in 
Usp9x−/Y brains is not due to decreased transcription.
The above results imply a direct correlation between Usp9x and Numb protein levels in neural cells. Numb is 
ubiquitylated by two RING E3 ligases Murine double minute (MDM2)51 and LNX52 targeting it for proteasomal 
degradation. However, no DUB has been reported to interact with NUMB. Therefore we sought to determine 
whether Usp9x binds Numb in the embryonic neocortex. Co-immunoprecipitation with Usp9x antibody from 
E14.5 Usp9x+/Y cortical lysates detected a strong interaction with Numb and, to a lesser extent, Itch (Fig. 7G). 
Reciprocal co-immunoprecipitation with Numb antibody immunoprecipitated Usp9x and Itch (Fig. 7H). In addi-
tion IHC analysis revealed extensive co-localisation of Usp9x and Numb in puncta in the basal, but not apical, 
domain of NPs in the VZ in E14.5 brains (n = 3) (Fig. 8). These results suggest that Usp9x positively regulates 
Numb in mouse NPs and that diminished Numb and Itch levels results in increased Notch signalling.
Discussion
NP fate is regulated by both extrinsic signalling pathways as well as intrinsic factors such as cell-cell adhesion and 
apical-basal cell polarity21. Usp9x is required for normal brain development6 but it was not clear what role, if any, 
it played in NPs. Nestin-Cre expression resulted in the complete deletion of Usp9x protein from NPs by E12.5 and 
expression of both AJ and polarity proteins was significantly decreased in Usp9x−/Y NPs at this stage (Fig. 1A–C). 
Functional annotation of microarray analysis identified cellular assembly, organisation, morphology and devel-
opment as the most significantly affected pathways in E12.5 Usp9x−/Y brains (Table S1). However, 48 hours later, 
at E14.5, all AJ and polarity proteins were detected at normal levels and localisations in Usp9x−/Y NPs (Fig. 1D–F).
One interpretation of these data is that Usp9x regulates the establishment, rather than maintenance, of NP 
adhesion/polarity similar to its role in other polarised epithelia. In cultured MDCKII cells Usp9x facilitates de 
novo tight junction assembly by regulating the temporal and spatial expression of the tight junction protein 
EFA68. Loss of Usp9x did not affect the morphology or function of mature tight junctions in MDCKII cells, but 
it significantly delayed their de novo formation after a calcium switch8. Similarly in T84 colon epithelial cells 
Usp9x interacted and colocalized with the cadherin-catenin heterodimer at points of protein trafficking in semi 
confluent cells establishing cell adhesion, but no association was detected with fully mature AJ complexes9. In 
NPs in-vivo Usp9x co-immunoprecipitated with both N-cadherin and β-catenin and the N-cadherin/β-catenin 
heterodimer was intact in E12.5 Usp9x−/Y brains (Supp. Fig. S6A), despite N-cadherin protein being significantly 
reduced at the apical domain. Therefore Usp9x may regulate trafficking of the N-cadherin/β-catenin heterodimer 
in NPs during AJ establishment as suggested in other epithelia. AJs and apical-basal cell polarity are functionally 
and structurally interconnected in NPs such that disrupting one perturbs the other53, 54. Therefore, delayed AJs 
establishment in Usp9x−/Y NPs would likely have been associated with a transient apical-basal polarity disruption 
in E12.5 Usp9x−/Y NPs. Similar conclusions have been reached following studies of MAL-3 knockout NPs, in 
which MAL-3 was shown to be important for the establishment rather than maintenance of AJs and polarity55. 
Likewise, the importance of Cdc42 in AJ establishment22 and in contrast, importance of RhoA in AJ mainte-
nance20 was concluded based on stage-specific cortical tissue dysmorphia in Cdc42 and RhoA mutant mice. 
Regarding the transient nature of the AJ and polarity disruption in Usp9x−/Y NPs, it remains possible that another 
DUB may compensate for the loss of Usp9x however the microarray analysis failed to detect up regulation of 
other DUBs in Usp9x−/Y brains.
In developing mammalian brains AJs contribute to the stem niche by connecting adjacent NPs, thus facilitat-
ing cell-cell communications that promote self-renewal. Disrupting AJs results in the premature differentiation 
of apical NPs into more fate restricted cell types21. Loss of Usp9x resulted in the increased number and density 
of Tbr2+ intermediate progenitors throughout the cortex, including many ectopically located in the VZ in E12.5 
Usp9x−/Y neocortex (Fig. 2A–F). Some Tbr2+ cells in the VZ also labelled with EdU or PH3 consistent with the 
premature differentiation of apical NPs to intermediate progenitors as occurs following the loss of other adhesion 
and polarity proteins including the small GTPases Cdc4222 and Rac123 as well as N-cadherin56, β-catenin57 and 
RhoA20. However, whilst Usp9x deletion induced the premature appearance of intermediate progenitors, it did 
not alter the overall production of neurons, as no difference was observed in the total neurogenesis or lamination 
pattern in Usp9x−/Y brains (Fig. 2G–L). Similarly, Nestin-Cre mediated deletion of aPKCλ also perturbed AJ 
formation and increased abventricular proliferation, but did not affect overall neurogenesis54. No difference was 
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observed in either cleaved Caspase3 or TUNNEL assays (Supp. Fig. S6A,B) suggesting cell death is unlikely to 
balance any persistent increase in neuronal numbers in the absence of Usp9x. Therefore the data presented herein 
strongly supports a role for Usp9x in the regulation of NP adhesion and polarity during neocortical development.
Figure 8. Usp9x co-localises with Numb in embryonic mouse brains. Coronal sections of E14.5 neocortices 
immunostained with Usp9x (red) and Numb (green) antibodies. Yellow arrows show extensive co-localization 
of Usp9x and Numb in the basal domain of NPs in the VZ. However Usp9x (red arrows) and Numb (green 
arrows) do not colocalise in the apical region above the nuclei (DAPI, blue) closest to the ventricle. LV- lateral 
ventricle, VZ-ventricular zone.
www.nature.com/scientificreports/
1 4Scientific RepoRts | 7: 8109  | DOI:10.1038/s41598-017-05451-5
In stark contrast to other AJ and polarity proteins, a clear increase in β-catenin protein was detected in 
Usp9x−/Y neocortices at all embryonic stages from E12.5 onward suggesting Usp9x regulates β-catenin inde-
pendently of its AJs function. As no change was observed in β-catenin mRNA levels, a translational and/or post-
translational defect was proposed to drive the β-catenin protein up regulation in Usp9x−/Y brains.
Significantly increased pβ-catenin33/37/41 levels in Usp9x−/Y brains suggested two things, (i) that the compo-
nents required to progressively phosphorylate β-catenin are present and functional in the destruction complex 
and, (ii) that either the progression of phosphorylated β-catenin or the activity of the ubiquitylation machinery 
within the destruction complex is hindered by the absence of Usp9x. Immunoblot analysis revealed the cellular 
levels of destruction complex proteins were unaltered and, immunoprecipitation confirmed the endogenous pro-
teins interacted in the absence of Usp9x (Figs 4D, S4B–I). However, the increased association between β-TrCP 
and GSK-3β in Usp9x−/Y brains (Fig. 4F,G) imply the stoichiometry of the complex may be altered. Normally 
pβ-catenin33/37/T41 is ubiquitylated within the destruction complex and rapidly degraded by the proteasome17 
as evident by minimal levels of this form of β-catenin in wild type neocortices (Fig. 3F). That WP1130 treatment 
of ReNcell VM produced an equivalent increase in β-catenin levels as proteasome inhibition strongly indicates the 
importance of deubiquitylase activity for this regulatory step. The precise mechanism whereby Usp9x regulates 
ubiquitylation within the destruction complex is yet to be elucidated as little is known about the sequential bio-
chemical reactions involved. However, a recent study demonstrated that during the Wnt-on state, β-TrCP mon-
oubiquitylates Gsk-3β58. This did not result in GSK-3β degradation nor affect its enzymatic activity, but instead 
increased the association between GSK-3β and β-TrCP which suppressed β-catenin recruitment to β-TrCP, lead-
ing to long-term inhibition of β-catenin ubiquitylation58. The increased interaction between GSK-3β and β-TrCP 
identified by both direct co-immunoprecipitation or indirectly via APC in Usp9x−/Y cortices (Fig. 4F,G) suggests 
β-TrCP may not dissociate from GSK-3β in the absence of Usp9x. Others have reported similarly higher levels of 
S33/37/T41 pβ-catenin in the cancer cell line SW480, which carries a truncated form of APC. However, similar to 
Usp9x−/Y brains both β-TrCP and Gsk-3β remained within the destruction complex59.
β-catenin protein levels are regulated by several DUBs including Usp7, Usp34, Usp4 and Usp4733–36, which 
oppose its proteasomal degradation. In contrast to the data presented here others have reported a positive correla-
tion between Usp9x and β-catenin protein levels. Previously Taya, et al.16 reported that over expression of Usp9x’s 
catalytic domain rescued β-catenin from proteasomal degradation in L cells. This apparently contradictory result 
may be due to either, (i) the differing roles of Usp9x in L-cells and embryonic NPs and/or (ii) the overexpres-
sion of Usp9x’s catalytic domain alone raises concerns about substrate specificity. USP9X also interacts with the 
cadherin-catenin homodimer at points of protein trafficking in semi-confluent T84 epithelial cells implying a 
subpopulation of USP9X interacts with the AJ-bound β-catenin (Murray et al.9). The co-immunoprecipitation of 
Usp9x with N-cadherin and β-catenin in the embryonic neocortex suggests this interaction also occurs in NPs in 
vivo. However this pool of β-catenin is not affected following Usp9x deletion and so did not alter total β-catenin 
levels.
The increase β-catenin levels raised the possibility that Wnt signalling might be activated in Usp9x−/Y neo-
cortices. However, the data indicate that any effect of Usp9x depletion on Wnt signalling is complex and cell 
context specific. While pβ-catenin33/37/41 levels were increased 6-fold in Usp9x−/Y neocortices, the transcrip-
tionally active form Tyr654 pβ-catenin was only slightly elevated (Fig. 3F–H). Similarly, expression of Wnt target 
gene Ccdn1 was clearly increased (by 60%) in-vivo but expression of Axin2 was only marginally elevated (3%) 
(Fig. 5A,B). A similar, if not somewhat enhanced, dynamic range in CCND1 (600%) and AXIN2 (25%) expres-
sion was detected in the ReNcell VM human NP cell line (Fig. 5E,F). Induction of CCND1 expression following 
USP9X depletion in ReNcell VM NPs was of a similar level as exposure to exogenous Wnt3a (Fig. 5H). Use of the 
TOPFlash reporter system demonstrated that depletion of USP9X is capable of directly activating Wnt transcrip-
tion, to the same level as exogenous Wnt3a, in HEK293 cells (Fig. 5C). Further, USP9X acts cell autonomously as 
the external Wnt inhibitor DKK1 does not affect it.
However, while ingenuity pathway analysis identified the Wnt pathway as significantly affected, the detected 
transcripts were components of Wnt pathway rather than targets. In addition, Ccnd1 is not an exclusive Wnt tar-
get gene but is regulated by numerous signalling pathways, including Notch60, 61.
In contrast to increased β-catenin levels, Numb and Itch protein levels decreased in Usp9x−/Y brains. The 
depletion of the E3 ubiquitin ligase Itch was not unexpected as Usp9x recuses it from auto-ubiquitylation and 
proteasomal degradation in multiple cell types15. However, the observation that Usp9x co-immunoprecipitates 
and co-localizes (Figs 7F–G, S9) with Numb in NPs, and Numb protein levels are clearly reduced in Usp9x−/Y 
neocortices (Fig. 7C–E) is novel. To our knowledge Usp9x is the first DUB shown to interact with, and main-
tain the levels of Numb, which is polyubiqutylated by the E3 ligases MDM251 and LNX52. Numb recruits Itch to 
membrane-tethered Notch receptors49. Usp9x immunoprecipitates within this complex, suggesting Usp9x may 
influence its stability and/or function. As a consequence of Usp9x deletion, NICD accumulated in Usp9x−/Y cor-
tices, and increased expression of Notch target genes. The slight but significantly increased Hes5 expression par-
alleled that of the Wnt target Axin2, suggesting a partial activation of Notch signalling. However, an increase in 
the BLBP expression suggested even this partial activation was sufficient to propagate a physiological response 
in Usp9x−/Y NPs.
Here we present data that Usp9x interacts with three independent mechanisms regulating NP function, 
namely, polarised cell adhesion, Wnt and Notch signalling. To some extent Usp9x appears capable of directly 
regulating components of all three pathways. Deletion of Usp9x transiently disrupted AJs and polarity in NPs 
resulting in the premature appearance and ectopic localisation of Tbr2+ intermediate progenitors. The most dra-
matic effect of Usp9x loss was the increase in β-catenin protein levels, especially pβ-catenin33/37/41. This was 
possibly due to altered stoichiometry of the β-catenin destruction complex in the absence of Usp9x. Loss of Usp9x 
also activated the Wnt signalling pathway and, at least in cultured cells, this can occur directly. However, in NPs 
in-vivo the effects are more modest. This may be due to the context specific role of both Usp9x5, 62, and β-catenin 
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transcriptional activation63 which are influenced by other signalling pathways. Indeed both Wnt and Notch acti-
vation increase Ccdn1 expression61, 64 and this may explain the more robust activation of this gene. We also show 
for the first time that Usp9x interacts with the Notch inhibitor Numb in NPs and loss of Usp9x significantly 
decreased Numb and Itch protein levels.
The effect of Usp9x deletion on NPs on brain development was not as severe as inhibition of each pathway 
alone possibly reflecting the counteracting roles of Notch and Wnt in progenitor cells40 Nonetheless, missense 
mutations in USP9X and loss of heterozygosity give rise to multiple neurodevelopmental disorders in humans65, 66  
and both USP9X gain of function and loss of function67 are tumorigenic in numerous cell types. The results 
presented here provide insight into some molecular mechanisms regulated by USP9X, which might be relevant 
to these pathologies. However, further experiments are warranted to elucidate how Usp9x integrates extrinsic 
pathways with cell adhesion and polarity.
Material and Methods
Animals. All animals were used and maintained in accordance with guidelines approved by the Griffith 
University Animal Ethics Committee under the animal ethics application BPS 02/11 and ESK06/14. The study 
followed the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Usp9x condi-
tionally deleted mice (Usp9x−/Y) were generated by mating Usp9xloxP/loxP female mice with Nestin-Cre male mice 
and the genotyping was conducted as described previously6.
Cell culture. HEK293 cells were maintained in DMEM supplemented with 10% fetal calf serum at 37 °C in 
an incubator with 5% CO2. ReNcell VM was obtained from Millipore (Darmstadt, Germany) and maintained 
according to the manufactures instructions. Doxycycline-inducible Usp9x knock-down ReNcell VMs were gen-
erated as described previously29, 68.
Immunohistochemistry. Time-mated mice were sacrificed by cervical dislocation; embryos were removed 
and dissected in ice-cold HBSS. Extracted embryonic heads were dropped fixed in 4% paraformaldehyde in PBS. 
The heads were then cryoprotected by immersion in 15% sucrose and 30% sucrose gradients and finally embed-
ded in Tissue-Tek Optimal Cutting Temperature compound (OTC) (Sakura). 10 μm coronal sections were made 
using Leica cryostat and mounted on Super Frost Plus microscope slides (Thermo Fisher Scientific). The sections 
were permeabilized using 1% SDS for 4 minutes then blocked with 2% BSA for 30 minutes at room temperature. 
Primary and secondary antibodies diluted in 2% BSA were incubated overnight at 4 °C and 1h at RT respectively. 
The used antibodies and their dilutions were listed in the Table S4.
Quantification. The cortex was defined as the area from the cortical hem to the pallial-subpallial boundary 
in each confocal image. Average NP and neuronal populations were measured as described69. Briefly, the VZ 
thickness was measured in a confocal image stained with SOX2 by first drawing a line at right angles to the ven-
tricular surface, from the apical surface to the pial surface. The length of this line was measured by ImageJ 1.60s 
software (National Institute of Health) and considered total cortical thickness. A line drawn from the apical to 
basal side of the SOX2-positive band was considered as VZ thickness. The average NP population was calculated 
as a ratio between the VZ and cortex thicknesses at five different points along the rostral-caudal axis in each image 
and the mean value of this ratio was used for all statistical analysis. The same method was used for the DCX pos-
itive cortical plate to measure the average neuronal population.
Immunoblot. Forebrains were dissected from extracted embryos, flash frozen with liquid Nitrogen and 
stored in -80 until use. Cortical tissues were lysed using lysis buffer (025 M Tris, 0.15 M NaCl, 0.001 M EDTA, 1% 
NP-40, 5% glycerol; pH 7.4) with 100 μl/mL protease and phosphatase inhibitor mix (Cell Signalling). Protein 
lysate was processed for immunoblotting and visualised with ECL substrate as described6. Antibodies used are 
listed in Table S5. Images of the full length immunoblots are presented in Supplementary data.
Co-immunoprecipitation. Proteins were extracted from embryonic mouse cortical tissues by sonication 
in the presence of IP lysis buffer - 20 mM HEPES pH 7.8, 400 mM KCl, 5 mM EDTA, 0.4% NP40, 10% glycerol, 
1 mM DTT, protease and phosphatase inhibitor cocktails (Cell Signalling). Immunoprecipitation was conducted 
using Pierce co-immunoprecipitation kit (Thermo Scientific) according to manufacturer’s instructions before 
being subjected to immunoblot analysis.
Quantitative RT-PCR and Microarray. RNA was isolated from cells or embryonic tissue using Trizol 
reagent (Invitrogen). The cDNA was generated using 2 μg of isolated RNA using the High capacity Reverse tran-
scription kit (Applied Biosystem) according to the manufacturer’s instructions. Quantitative real reactions were 
conducted on the Rotor gene 6000 (Corbett Life Science) using the SensiFAST HRM kit (Bioline). All samples 
were run in quadruples and normalised to GAPDH expression. Primer sequences listed in Table S6. For each 
genotype four embryos were used for microarray analyses. 500 ng of total RNA was processed using Ambion 
Illumina TotalPrep RNA amplification kit and cRNAs were hybridized to Illumina MouseRef-8 v2.0 Expression 
BeadChips (Illumina) and scanned on an Illumina Beadstation. Data was process and quantile normalised using 
R/BioConductor lumi package as described previously70. Differentially expressed transcripts were identified 
using the limma package - (-linear models for microarray71, at p = 0.05. Functional over-representation analysis 
was determined using right-tailed Fisher’s exact test using Ingenuity Pathway Analysis 8.5 (Ingenuity Systems). 
Microarray data was deposited into ArrayExpress (Accession Number E-MTAB-4150). Differentially expressed 
genes were clustered using Euclidean distance65 in Cluster 3.0 and visualized in Java Freeview66.
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Luciferase assay. USP9X expression was depleted in HEK293 cells using USP9X siRNA obtained from 
Millenium Science (SMARTpool ON-TARGETplus USP9x siRNA Cat# L-006099-00-0005) was used to knock-
down USP9X. Scrambled siRNA (ON-TARGETplus Non-targeting Pool Cat# D-001810-10-05) was used as con-
trol. USP9X-depleted HEK293 cells were then transfected with plasmids pGL3-TOP and pGL3-FOP containing 
TCF luciferase-reporter construct72 using Lipofectamine 2000 reagent (Invitrogen). Wnt3A or DKK1 added to 
the cells 24 hours after the transfection. 1 hour after the Wnt3a (100 ng/µl) (R&D system Cat# 5036-WN) and 
DKK1 (100 ng/µl) (Sigma Cat# SRO3258) treatment, cells were lysed using luciferase lysis buffer (Promega). To 
measure the luciferase activity, 10 μl of cell lysate was transferred to a black 96-well Optiplate (Perkin Elmer). 
Luciferase activities were performed in triplicate.
Statistical analysis. Statistical analysis was performed using Prism 5 (GraphPad Prism). For all analysis at 
least three biological repeats were assessed. Statistical analysis was perform using one-way ANOVA and Tukey’s 
post-hoc tests, for experiments containing more than two samples, or with a Student T-test for data sets with 
only two samples. The error bars on all the graphs represent SEM. All the values were presented as mean ± SEM.
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